5.800
−6,45%
2026-10-19
Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +103.1% | +43.5% | 2 / 3 | -56.1% | +32.83 pp | +10.11 pp | +0.3% | 0.00 | 194.24 | 1,3 | −56,1% | 0,0 | +115,6% | 194.24 | 18.97 | +923,9% |
| Pts | 12 | 8 | 8 | 0 | 12 | 12 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 5.800 (close price on 2026-10-19)EPS (TTM): 29,9
Financial charts
1.Revenue & growth
VND bn1,27Q2/26
1.Revenue & growth
VND bn1,27Q2/26
2.Profit & growth
VND bn-0,54Q2/26
3.Profit mix (Penman)
VND bn-0,40Q2/26
4.Margins & cost structure
%45.4%Q2/26
5.Returns & cash cycle
% · days-43.9%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn67,5Q2/26
8.Funding & debt health
VND bn · times67,5Q2/26
9.Revenue backlog
VND bn0,64Q2/26
10.Valuation
times · %-61,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-108Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-99.5%
averaged over 1 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
400%
Source: vnstockData through Q2/26